Online Program Home
My Program

CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

614 * ! Thu, 8/2/2018, 8:30 AM - 10:20 AM CC-West 110
Reasonable Possibility - Statistical Science of Safety Monitoring — Topic Contributed Papers
Biopharmaceutical Section, Quality and Productivity Section
Organizer(s): Hal Li, Merck Research Laboratories
Chair(s): Judy Li, Regeneron Pharmaceuticals Inc.
8:35 AM Beware On-Treatment Safety Analysis

Janet Wittes, Statistics Collaborative; Fred Yang, Innomed Consulting
8:55 AM The Likelihood Principle and Its Application to Aggregate Safety Monitoring
LiAn Lin; Bill Wang, Merck
9:15 AM Visual Analytics to Assess Reasonable Possibility: Using DILI as an Example

Kefei Zhou, Theravance Biopharma; Melvin Munsaka, AbbVie, Inc.; Krishan P. Singh, GlaxoSmithKline
9:35 AM Practical Considerations in Planning and Implementing Aggregate Safety Monitoring

Bill Wang, Merck
9:55 AM Floor Discussion